Daclizumab monoclonal antibody drug. Targets CD25 (alpha subunit of IL-2 receptor on T-cells) and is used in treatment of multiple sclerosis. Generic

---

Daclizumab monoclonal antibody drug. Targets CD25 (alpha subunit of IL-2 receptor on T-cells) and is used in treatment of multiple sclerosis. Generic name and stylized antibody.

---

Size: 9000px × 3504px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: -cell, antibody, biological, biosimilar, biotech, biotechnology, cd25, daclizumab, disease, drug, il-2, immunoglobulin, immunology, infusion, injection, inn, mab, monoclonal, ms, multiple, nomenclature, peptide, protein, receptor, rejection, scleroris, transplant